103 related articles for article (PubMed ID: 12215562)
1. Rationale of 5-(125)I-iodo-4'-thio-2'-deoxyuridine as a potential iodinated proliferation marker.
Toyohara J; Hayashi A; Sato M; Tanaka H; Haraguchi K; Yoshimura Y; Yonekura Y; Fujibayashi Y
J Nucl Med; 2002 Sep; 43(9):1218-26. PubMed ID: 12215562
[TBL] [Abstract][Full Text] [Related]
2. Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridine.
Morgenroth A; Deisenhofer S; Glatting G; Kunkel FH; Dinger C; Zlatopolskiy B; Vogg AT; Kull T; Reske SN
Clin Cancer Res; 2008 Nov; 14(22):7311-9. PubMed ID: 19010846
[TBL] [Abstract][Full Text] [Related]
3. Development of radioiodinated nucleoside analogs for imaging tissue proliferation: comparisons of six 5-iodonucleosides.
Toyohara J; Hayashi A; Sato M; Gogami A; Tanaka H; Haraguchi K; Yoshimura Y; Kumamoto H; Yonekura Y; Fujibayashi Y
Nucl Med Biol; 2003 Oct; 30(7):687-96. PubMed ID: 14499326
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution, cellular uptake and DNA-incorporation of the 2'-fluoro stabilized 5-iodo-2'-deoxyuridine analog 5-iodo-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU).
Morgenroth A; Deisenhofer S; Neininger M; Vogg AT; Glatting G; Kull T; Reske SN
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):305-16. PubMed ID: 18432182
[TBL] [Abstract][Full Text] [Related]
5. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
[TBL] [Abstract][Full Text] [Related]
6. Auger electron emitter against multiple myeloma--targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4'-thio-2'-deoxyuridine.
Morgenroth A; Dinger C; Zlatopolskiy BD; Al-Momani E; Glatting G; Mottaghy FM; Reske SN
Nucl Med Biol; 2011 Oct; 38(7):1067-77. PubMed ID: 21982576
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism of 5-125I-iodo-4'-thio-2'-deoxyuridine in rodents.
Toyohara J; Gogami A; Hayashi A; Yonekura Y; Fujibayashi Y
J Nucl Med; 2003 Oct; 44(10):1671-6. PubMed ID: 14530485
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging.
Toyohara J; Kumata K; Fukushi K; Irie T; Suzuki K
J Nucl Med; 2006 Oct; 47(10):1717-22. PubMed ID: 17015909
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.
Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS
J Nucl Med; 2004 Dec; 45(12):2063-9. PubMed ID: 15585483
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
11. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.
Najjar AM; Nishii R; Maxwell DS; Volgin A; Mukhopadhyay U; Bornmann WG; Tong W; Alauddin M; Gelovani JG
J Nucl Med; 2009 Mar; 50(3):409-16. PubMed ID: 19223410
[TBL] [Abstract][Full Text] [Related]
12. A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2'-fluoro-2'-deoxyuridine.
Morin KW; Duan W; Knaus EE; McEwan AJ; Wiebe LI
Nucl Med Biol; 2005 Jul; 32(5):459-64. PubMed ID: 15982576
[TBL] [Abstract][Full Text] [Related]
13. Alkyl-fluorinated thymidine derivatives for imaging cell proliferation II. Synthesis and evaluation of N3-(2-[18F]fluoroethyl)-thymidine.
Toyohara J; Hayashi A; Gogami A; Fujibayashi Y
Nucl Med Biol; 2006 Aug; 33(6):765-72. PubMed ID: 16934695
[TBL] [Abstract][Full Text] [Related]
14. Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers.
Rösler TW; Matusch A; Librizzi D; Arias-Carrión O; Freundlieb N; Hoeffken H; Oertel WH; Depboylu C; Höglinger GU
PLoS One; 2014; 9(7):e102397. PubMed ID: 25028935
[TBL] [Abstract][Full Text] [Related]
15. Preparation of 5-[131I]iodo- and 5-[211At]astato-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil by a halodestannylation reaction.
Vaidyanathan G; Zalutsky MR
Nucl Med Biol; 1998 Jul; 25(5):487-96. PubMed ID: 9720667
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo.
Bauwens M; Lahoutte T; Kersemans K; Gallez C; Bossuyt A; Mertens J
Nucl Med Biol; 2006 Aug; 33(6):735-41. PubMed ID: 16934692
[TBL] [Abstract][Full Text] [Related]
17. Radioactive nucleic acids-precursors: their potential value as tumor-localizing agents.
Anghileri LJ; Heidbreder M; Mathes R
Strahlentherapie; 1977 Jun; 153(6):433-6. PubMed ID: 195368
[TBL] [Abstract][Full Text] [Related]
18. EdU incorporation is an alternative non-radioactive assay to [(3)H]thymidine uptake for in vitro measurement of mice T-cell proliferations.
Yu Y; Arora A; Min W; Roifman CM; Grunebaum E
J Immunol Methods; 2009 Oct; 350(1-2):29-35. PubMed ID: 19647746
[TBL] [Abstract][Full Text] [Related]
19. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
Semnani ES; Wang K; Adelstein SJ; Kassis AI
J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of cellular kinetics of reporter probe [(131)I]FIAU in neonatal cardiac myocytes after transfer of HSV1-tk reporter gene with two vectors.
Lan X; Yin X; Wang R; Liu Y; Zhang Y
Nucl Med Biol; 2009 Feb; 36(2):207-13. PubMed ID: 19217533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
